HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jong-Soon Kang Selected Research

18-dehydroxyl-17-demethoxyreblastatin

10/2014Anti-tumor activity of WK88-1, a novel geldanamycin derivative, in gefitinib-resistant non-small cell lung cancers with Met amplification.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jong-Soon Kang Research Topics

Disease

6Neoplasms (Cancer)
03/2022 - 01/2011
1Inflammation (Inflammations)
01/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2014
1Lung Neoplasms (Lung Cancer)
10/2014
1Stomach Neoplasms (Stomach Cancer)
01/2012
1Infections
01/2012
1Carcinogenesis
01/2012
1Necrosis
01/2012
1Asthma (Bronchial Asthma)
01/2006

Drug/Important Bio-Agent (IBA)

2Transcription Factors (Transcription Factor)IBA
01/2021 - 01/2012
1Type I DNA Topoisomerases (Topoisomerase I)IBA
03/2022
11,2,3,4-tetrahydroisoquinolineIBA
01/2021
16-hydroxy-7-methoxychroman-2-carboxylic acid phenylamideIBA
01/2021
1Proteasome Endopeptidase Complex (Proteasome)IBA
12/2020
1Inhibitor of Apoptosis ProteinsIBA
12/2020
1CaspasesIBA
12/2020
1Biomarkers (Surrogate Marker)IBA
12/2020
118-dehydroxyl-17-demethoxyreblastatinIBA
10/2014
1geldanamycinIBA
10/2014
1Gefitinib (Iressa)FDA Link
10/2014
1Tyrosine Kinase InhibitorsIBA
10/2014
1ErbB Receptors (EGF Receptor)IBA
10/2014
1Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
01/2012
1Proteins (Proteins, Gene)FDA Link
01/2012
1VitaminsIBA
01/2012
1Cholecalciferol (Vitamin D3)FDA Link
01/2012
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2012
1titanium dioxide (Titania)FDA Link
01/2011
1Immunoglobulin E (IgE)IBA
01/2006
1B-Cell Activating FactorIBA
01/2006

Therapy/Procedure

1Drug Therapy (Chemotherapy)
03/2022
1Immunomodulation
01/2011